A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer.

Takanori AbeYasuhiro RyunoMisaki IinoSatoshi SaitoTomomi AoshikaTomohiro OhtaMitsunobu IgariRyuta HiraiYu KumazakiKyoichi KairaHiroshi KagamuHironori IshidaShin-Ei NodaShingo Kato

Published in: Japanese journal of clinical oncology (2021)

We found CyberKnife-stereotactic body radiotherapy for pathologically confirmed T1b-T2aN0M0 non-small cell lung cancer to be effective and safe. However, these results should be validated with a larger patient cohort and prospective follow-up monitoring.

Keyphrases

early stage
locally advanced
radiation therapy
radiation induced
case report
squamous cell carcinoma
rectal cancer